Loading...
Please wait, while we are loading the content...
Similar Documents
Combination of nivolumab (nivo) + ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer (mCRC): CheckMate 142 Study.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Lonardi, Sara André, Thierry Wong, Ka Yeung Mark Morse, Michael McDermott, Raymond S. Hill, Andrew F. Hendlisz, Alain Lenz, H. Leach, Joseph Moss, Rebecca Anne Cao, Z. Alexander Ledeine, J-M. Kopetz, Scott Overman, Michael J. |
| Copyright Year | 2017 |
| Starting Page | vi3 |
| Ending Page | vi3 |
| Page Count | 1 |
| File Format | PDF HTM / HTML |
| DOI | 10.1093/annonc/mdx422.001 |
| PubMed reference number | 31962658 |
| Journal | Medline |
| Volume Number | 28 |
| Alternate Webpage(s) | http://www.bmsmedicalpublications.com/posters/NIV-2017-030929.PDF |
| Alternate Webpage(s) | https://doi.org/10.1093/annonc%2Fmdx422.001 |
| Journal | Annals of oncology : official journal of the European Society for Medical Oncology |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |